Metabolic aspects of peroxisomal disorders

Annals of the New York Academy of Sciences

Volumn 804, Issue , 1996, Pages 450-460

  Wanders, R J A ^a   Jansen, G ^a   Van Roermund, C W T ^a   Denis, S ^a   Schutgens, R B H ^a   Jakobs, B S ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; PHOSPHOLIPID; PHYTANIC ACID; PIPECOLIC ACID;

ADRENOLEUKODYSTROPHY; CHONDRODYSPLASIA PUNCTATA; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE CLASSIFICATION; DISORDERS OF PEROXISOMAL FUNCTIONS; FATTY ACID OXIDATION; HUMAN; HYPOCHOLESTEROLEMIA; METABOLIC DISORDER; PHOSPHOLIPID SYNTHESIS; REFSUM DISEASE; ZELLWEGER SYNDROME;

EID: 0030450007     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb18636.x     Document Type: Conference Paper

References (38)

1. GOLDFISCHER, S., C. L. MOORE, A. B. JOHNSON, A. J. SPIRO, M. P. VALSAMIS, H. K. WISNIEWKi, R. H. RITCH, W. T. NORTON, I. RAPIN & L. M. GARTNER. 1973. Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome. Science 182: 62-64.
2. BROWN, F. R., A. J. MCADAMS, J. W. CUMMINS, R. KONKOL, I. SINGH, A. E. MOSER & H. W. MOSER. 1982. Cerebro-hepato-renal (Zellweger) syndrome and neonatal adrenoleukodystrophy: Similarities in phenotype and accumulation of very long chain fatty acids. John Hopkins Med. J. 151: 344-361.
3. HEIJMANS, H. S. A., R. B. H. SCHUTGENS, R. TAN, H. VAN DEN BOSCH & P. BORST. 1983. Severe plasmalogen deficiency in tissues of infants without peroxisomes. Nature (London) 306: 69-70.
4. WANDERS, R. J. A., R. B. H. SCHUTGENS, P. G. BARTH, J. M. TAGER & H. VAN DEN BOSCH. 1993. Postnatal diagnosis of peroxisomal disorders: A biochemical approach. Biochimie 75: 269-279.
5. REDDY, J. K. & G. P. MANNAERTS. 1994. Peroxisomal lipid metabolism. Annu.Rev.Nutr. 14: 343-370.
6. LAZAROW, P. B. & H. W. MOSER. 1995. Disorders of peroxisome biogenesis. In The Metabolic and Molecular Bases of Inherited Disease C. R. Scriver, A. L. Beadet, W. S. Sly & D. Valle, Eds. Vol. 5: 2287-3324. McGraw-Hill, New York.
7. WANDERS, R. J. A. & C. W. T. VAN ROERMUND. 1993. Studies on phytanic acid alpha-oxidation in rat liver and cultured skin fibroblasts. Biochim.Biophys. Acta 1167: 345-350.
8. TEN BRINK, H. J., F. STELLAARD, C. M. M. VAN DE HEUVEL, D. S. M. SCHOR, R. J. A. WANDERS & C. JAKOBS. 1992. Pristanic acid and phytanic acid in plasma from patients with peroxisomal disorders: Stable isotope dilution analysis with electron capture negative ion mass fragmentography. J.Lipid Res. 33: 31-37.
9. WANDERS, R. J. A., C. W. T. VAN ROERMUND, D. S. M. SCHOR, H. J. TEN BRINK & C. JACOBS. 1994. 2-Hydroxyphytanic acid oxidase activity in rat and human liver and its deficiency in the Zellweger syndrome. Biochim.Biophys.Acta 1227: 177-182.
10. SINGH, I., K. PAHAN, G. S. DHAUNSI, O. LAZO & P. OZAND. 1993. Phytanic acid alpha-oxidation: differential subcellular localization in rat and human tissues and its inhibition by Nycodenz. J.Biol.Chem. 268: 9972-9979.
11. POULOS, A., P. SHARP, H. SINGH, D. W. JOHNSON, W. F. CAREY & C. EASTON. 1993. Formic acid is a product of the alpha-oxidation of fatty acids by human skin fibroblasts: Deficiency of formic acid production in peroxisome deficient fibroblasts. Biochem.J. 292: 457-461.
12. CASTEELS, M., K. CROES, P. P. VAN VELDHOVEN & G. P. MANNAERTS. 1994. Aminotriazole is a potent inhibitor of alpha-oxidation of 3-methyl-substituted fatty acids in rat liver. Biochem. Pharmacol. 48: 1973-1975.
13. METZLER, D. E. 1977. Biochemistry: The chemical reactions of living cells. Academic Press. London.
14. PAHAN, K., J. COFER, P. BALIGA & I. SINGH. 1993. Identification of phytanoyl-CoA ligase as a distinct acyl-CoA ligase in peroxisomes from cultured skin fibroblasts. FEBS Lett. 322: 101-104.
15. SINGH, H. & A. POULOS. 1995. Substrate specificity of rat liver mitochondrial carnitine palmitoyl-transferase I: Evidence against a-oxidation of phytanic acid in rat liver mitochondria. FEBS Lett. 359: 179-183.
16. WATKINS, P.A., A.E. HOWARD & S.J. MIHALIK. 1994. Phytanic acid must be activated to phytanoyl-CoA prior to its α-oxidation in rat liver peroxisomes. Biochim. Biophys. Acta 1214: 288-294.
17. MARTINEZ, M. 1990. Severe deficiency of docosahexaenoic acid in peroxisomal disorders: a defect in 4-desaturase. Neurology 40: 1292-1298.
18. VOSS, A., M. REINHART, S. SANKARAPPA & H. SPRECHER. 1991. The metabolism of 7,10,13,16,19- docosapentaenoic acid to 4,7,10,13,16,19- docosahexaenoic acid in rat liver is independent of a 4-desaturase. J.Biol.Chem. 266: 19995-20000.
19. HODGE, V. J., S. G. GOULD, S. SUBRAMANI, H. W. MOSER & S. K. KRISANS. 1991. Normal cholesterol biosynthesis in human cells requires functional peroxisomes. Biochem. Biophys. Res. Commun. 181: 537-541.
20. MALLE, E., K. OETTL, W. SATTLER, G. HOEFLER & G. M. KOSTNER. 1995. Cholesterol biosynthesis in dermal fibroblasts from patients with metabolic disorders of peroxisomal origin. Eur. J. Clin. Invest. 25: 59-67.
21. POLL-THE, B. T., F. ROELS, H. OGIER & H. SCOTTO. 1988. A new peroxisomal disorder with enlarged peroxisomes and a specific deficiency of acyl-CoA oxidase. Am. J. Hum. Genet. 42: 422-434.
22. WATKINS, P. A., W. W. CHEN, C.J. HARRIS, G. HOEFLER, S. HOEFLER, D. C. BLAKE, R. I. KELLEY, A. B. MOSER, M. E. BEARD & H. W. MOSER. 1989. Peroxisomal bifunctional enzyme deficiency. J.Clin.Invest. 83: 771-777
23. SCHRAM, A. W., S. GOLDFISCHER, C. W. T. VAN ROERMUND, J. COLLINS, T. HASHIMOTO, H. S. A. HEYMANS, H. VAN DEN BOSCH, J. M. TAGER & R. J. A. WANDERS. 1987. Human peroxisomal 3-oxoacyl-coenzyme A thiolase deficiency. Proc.Natl. Acad.Sci. USA 84: 2492-2496.
24. WANDERS, R. J. A., R. B. H. SCHUTGENS & P. BARTH. 1995. Peroxisomal disorders: A review. J. Neuropathol. Exp. Neurol. 54: 726-739.
25. MCGUINESS, M. C., A. B. MOSER, H. W. MOSER & P. B. WATKINS. 1990. Peroxisomal disorders: Complementation analysis using β-oxidation of very long chain fatty acids. Biochem. Biophys. Res. Commun. 172: 364-369.
26. WANDERS, R. J. A., C. W. T. VAN ROERMUND, S. BRUL, R. B. H. SCHUTGENS & J. M. TAGER. 1992. Bifunctional protein deficiency. J. Inher. Metab. Dis. 15: 389-391.
27. SUZUKI, Y., N. SHIMOZAWA, S. YAJIMA, S. TOMATSU, N. KONDO, Y. NAKADA, S. AKABOSHI, M. IAI, Y. TANABE, T. HASHIMOTO, R. J. A. WANDERS, R. B. H. SCHUTGENS, H. W. MOSER & T. ORII. 1994. Novel subtype of peroxisomal acyl-CoA oxidase deficiency and bifunctional enzyme deficiency with detectable enzyme protein: Identification by means of complementation analysis. Am. J. Hum. Genet. 54: 36-43.
28. WANDERS, R. J. A., A. SCHELEN, N. FELLER, R. B. H. SCHUTGENS, F. STELLAARD, C. JAKOBS, B. MITULLA & G. SEIDLITZ. 1990. First prenatal diagnosis of acyl-CoA oxidase deficiency. J. Inher. Metab. Dis. 13: 371-374.
29. MOTLEY, A., E. HETTEMA, B. DISTEL & H. TABAK. 1994. Differential protein import deficiencies in human peroxisome assembly disorders. J. Cell. Biol. 125: 755-767.
30. MARZIOCH, M., R. ERDMANN, M. VEENHUIS & W. H. KUNAU. 1994. PAS7 encodes a novel yeast member of the WD-40 protein family essential for import of 3-oxoacyl-CoA thiolase, a PTS2-containing protein, into peroxisomes. EMBO J. 13: 4908-4917.
31. WANDERS, R. J. A., H. SCHUMACHER, J. HEIKOOP, R. B. H. SCHUTGENS & J. M. TAGER. 1992. Human dihydroxyacetonephosphate acyltransferase deficiency: A new peroxisomal disorder. J. Inher. Metab. Dis. 15: 389-391.
32. WANDERS, R. J. A., A. C. DEKKER, V. A. P. HORVATH, R. B. H. SCHUTGENS, J. M. TAGER, P. VAN LAER & D. LECOUTERE. 1994. Human alkyldihydroxyacetone phosphate synthase deficiency: A new peroxisomal disorder. J. Inher. Metab. Dis. 17: 315-318.
33. Zoeller, R.A., O. H. Morand & C. R .H. Raetz. 1988. A possible role for plasmalogens in protecting animal cells against photosensitized killing. J. Biol. Chem. 263: 11590-11596.
34. JANSEN, G. A. & R. J. A. WANDERS. 1996. Plasmalogens and oxidative stress: Evidence against a major role of plasmalogens in protection against the superoxide anion radical. J. Inher. Metab. Dis. In press.
35. MIHALIK, S. J., A. N. RAINVILLE & P. A. WATKINS. 1995. Phytanic acid β-oxidation in rat liver peroxisomes: Production of α-hydroxyphytanoyl-CoA and formate is enhanced by dioxygenase cofactors. Eur. J. Biochem. 232: 545-551.
36. JANEN, G. A., S. J. MIHALIK, P. A. WATKINS, H. W. MOSER, C. JAKOBS, S. DENIS & R. J. A. WANDERS, 1996. Phytanoyl-CoA hydroxylase is present in human liver, located in peroxisomes, and deficient in Zellweger syndrome. Biochem. Biophys. Res. Commun. In press.
37. JANSEN, G. A., S. J. MAHALIK, P. A. WATKINS, H. W. MOSER, C. JAKOBS, H. S. A. HEIJMANS & R. J. A. WANDERS. 1997. Phytanoyl-CoA hydroxylase is not only deficient in classical Refsum disease but also in rhizomelic chondrodysplasia punctata. J. Inher. Metab. Dis. In press.
38. JANSEN, G. A., R. J. A. WANDERS, C. J. DE GROOT, C. JAKOBS, H. W. MOSER, P. A. WATKINS & S. J. MIHALIK. 1996. Phytanoyl-CoA hydroxylase deficiency: Discovery of the long sought enzyme defect in Refsum disease and a possible therapy. N. Engl. J. Med. Submitted for publication.